Dr. Kieuhoa T. Vo
Claim this profileUCSF Medical Center-Mission Bay
Expert in Tumors
Studies Neuroblastoma
21 reported clinical trials
31 drugs studied
About Kieuhoa T. Vo
Education:
- Obtained a BS in Biological Sciences with a minor in Anthropology from the University of Notre Dame (2000-2004).
- Earned an MD from Indiana University School of Medicine (2004-2008).
- Completed a MAS in Clinical Research from the University of California, San Francisco (2013-2015).
Experience:
- Completed Residency in Pediatrics at Nationwide Children's Hospital, Ohio State University (2008-2011).
- Undertook a Fellowship in Pediatric Hematology/Oncology at UCSF Benioff Children's Hospital (2012-2015).
- Serves as an Associate Professor in the Department of Pediatrics at UCSF Benioff Children's Hospital.
- Focuses research on novel prognostic and predictive biomarkers for improved therapies in pediatric solid tumors.
Area of expertise
1Tumors
Global LeaderStage IV
NTRK1 positive
NTRK positive
2Neuroblastoma
Stage IV
MYC positive
ALK positive
Affiliated Hospitals
Clinical Trials Kieuhoa T. Vo is currently running
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
Olaparib + Ceralasertib
for Recurrent Osteosarcoma
This study is being done in order to evaluate the effectiveness of using two drugs (olaparib and ceralasertib) to treat patients with osteosarcoma that has not responded to treatment or has come back after treatment The names of the study drugs involved in this study are: * Olaparib * Ceralasertib
Recruiting2 awards Phase 24 criteria
More about Kieuhoa T. Vo
Clinical Trial Related3 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Kieuhoa T. Vo has experience with
- Lorlatinib
- Cytarabine
- Tissue Sample Collection
- Blood Sample Collection
- Bone Marrow Sample Collection
- Cyclophosphamide
Breakdown of trials Kieuhoa T. Vo has run
Tumors
Neuroblastoma
Recurrence
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kieuhoa T. Vo specialize in?
Kieuhoa T. Vo focuses on Tumors and Neuroblastoma. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are NTRK1 positive.
Is Kieuhoa T. Vo currently recruiting for clinical trials?
Yes, Kieuhoa T. Vo is currently recruiting for 6 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Kieuhoa T. Vo has studied deeply?
Yes, Kieuhoa T. Vo has studied treatments such as Lorlatinib, Cytarabine, Tissue Sample Collection.
What is the best way to schedule an appointment with Kieuhoa T. Vo?
Apply for one of the trials that Kieuhoa T. Vo is conducting.
What is the office address of Kieuhoa T. Vo?
The office of Kieuhoa T. Vo is located at: UCSF Medical Center-Mission Bay, San Francisco, California 94158 United States. This is the address for their practice at the UCSF Medical Center-Mission Bay.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.